Number of the records: 1

certolizumab pegol

	MeSH Tree Structures - certolizumab pegol `[d05.750.741.125]` látky makromolekulárne [d05] + polyméry [d05.750] + polyetylénglykoly [d05.750.741] + certolizumab pegol `[d05.750.741.125]` cetomakrogol [d05.750.741.250] hydrogél, polyetylénglykol dimetakrylát [d05.750.741.485] nonoxynol [d05.750.741.575] oktoxynol [d05.750.741.610] polidokanol [d05.750.741.630] poloxalén [d05.750.741.650] poloxamér [d05.750.741.667] polyhydroxyetylmetakrylát [d05.750.741.685] polysorbáty [d05.750.741.700]
	`[d12.644.541.500.650.250]` aminokyseliny, peptidy a proteíny [d12] + peptidy [d12.644] + fragmenty peptidové [d12.644.541] + fragmenty imunoglobulínov [d12.644.541.500] + Fab fragmenty imunoglobulínov [d12.644.541.500.650] + abciximab [d12.644.541.500.650.125] certolizumab pegol `[d12.644.541.500.650.250]` oblasť imunoglobulínov, variabilná [d12.644.541.500.650.500] + tuftsín [d12.644.541.500.650.750]
	`[d12.776.124.486.485.114.224.060.500]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + imunoproteíny [d12.776.124.486] + imunoglobulíny [d12.776.124.486.485] + protilátky [d12.776.124.486.485.114] + protilátky monoklonálne [d12.776.124.486.485.114.224] + protilátky monoklonálne humanizované [d12.776.124.486.485.114.224.060] + abciximab [d12.776.124.486.485.114.224.060.125] adalimumab [d12.776.124.486.485.114.224.060.250] alemtuzumab [d12.776.124.486.485.114.224.060.313] baziliximab [d12.776.124.486.485.114.224.060.344] bevacizumab [d12.776.124.486.485.114.224.060.375] brentuximab vedotin [d12.776.124.486.485.114.224.060.438] certolizumab pegol `[d12.776.124.486.485.114.224.060.500]` cetuximab [d12.776.124.486.485.114.224.060.750] daklizumab [d12.776.124.486.485.114.224.060.766] denosumab [d12.776.124.486.485.114.224.060.782] gemtuzumab [d12.776.124.486.485.114.224.060.790] inotuzumab ozogamicín [d12.776.124.486.485.114.224.060.794] ipilimumab [d12.776.124.486.485.114.224.060.798] natalizumab [d12.776.124.486.485.114.224.060.813] nivolumab [d12.776.124.486.485.114.224.060.829] omalizumab [d12.776.124.486.485.114.224.060.844] palivizumab [d12.776.124.486.485.114.224.060.860] panitumumab [d12.776.124.486.485.114.224.060.864] ramucirumab [d12.776.124.486.485.114.224.060.866] ranibizumab [d12.776.124.486.485.114.224.060.868] trastuzumab [d12.776.124.486.485.114.224.060.875] + ustekinumab [d12.776.124.486.485.114.224.060.937]
	`[d12.776.124.486.485.680.650.250]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + imunoproteíny [d12.776.124.486] + imunoglobulíny [d12.776.124.486.485] + fragmenty imunoglobulínov [d12.776.124.486.485.680] + Fab fragmenty imunoglobulínov [d12.776.124.486.485.680.650] + abciximab [d12.776.124.486.485.680.650.125] certolizumab pegol `[d12.776.124.486.485.680.650.250]` oblasť imunoglobulínov, variabilná [d12.776.124.486.485.680.650.500] + tuftsín [d12.776.124.486.485.680.650.750]
	`[d12.776.124.790.651.114.224.060.500]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + globulíny sérové [d12.776.124.790] + imunoglobulíny [d12.776.124.790.651] + protilátky [d12.776.124.790.651.114] + protilátky monoklonálne [d12.776.124.790.651.114.224] + protilátky monoklonálne humanizované [d12.776.124.790.651.114.224.060] + abciximab [d12.776.124.790.651.114.224.060.125] adalimumab [d12.776.124.790.651.114.224.060.250] alemtuzumab [d12.776.124.790.651.114.224.060.375] baziliximab [d12.776.124.790.651.114.224.060.407] bevacizumab [d12.776.124.790.651.114.224.060.438] brentuximab vedotin [d12.776.124.790.651.114.224.060.469] certolizumab pegol `[d12.776.124.790.651.114.224.060.500]` cetuximab [d12.776.124.790.651.114.224.060.750] daklizumab [d12.776.124.790.651.114.224.060.766] denosumab [d12.776.124.790.651.114.224.060.782] gemtuzumab [d12.776.124.790.651.114.224.060.790] inotuzumab ozogamicín [d12.776.124.790.651.114.224.060.794] ipilimumab [d12.776.124.790.651.114.224.060.798] natalizumab [d12.776.124.790.651.114.224.060.813] nivolumab [d12.776.124.790.651.114.224.060.829] omalizumab [d12.776.124.790.651.114.224.060.844] palivizumab [d12.776.124.790.651.114.224.060.860] panitumumab [d12.776.124.790.651.114.224.060.864] ramucirumab [d12.776.124.790.651.114.224.060.866] ranibizumab [d12.776.124.790.651.114.224.060.868] trastuzumab [d12.776.124.790.651.114.224.060.875] + ustekinumab [d12.776.124.790.651.114.224.060.937]
	`[d12.776.124.790.651.680.650.250]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + globulíny sérové [d12.776.124.790] + imunoglobulíny [d12.776.124.790.651] + fragmenty imunoglobulínov [d12.776.124.790.651.680] + Fab fragmenty imunoglobulínov [d12.776.124.790.651.680.650] + abciximab [d12.776.124.790.651.680.650.125] certolizumab pegol `[d12.776.124.790.651.680.650.250]` oblasť imunoglobulínov, variabilná [d12.776.124.790.651.680.650.500] + tuftsín [d12.776.124.790.651.680.650.750]
	`[d12.776.377.715.548.114.224.200.500]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + globulíny [d12.776.377] + globulíny sérové [d12.776.377.715] + imunoglobulíny [d12.776.377.715.548] + protilátky [d12.776.377.715.548.114] + protilátky monoklonálne [d12.776.377.715.548.114.224] + protilátky monoklonálne humanizované [d12.776.377.715.548.114.224.200] + abciximab [d12.776.377.715.548.114.224.200.125] adalimumab [d12.776.377.715.548.114.224.200.250] alemtuzumab [d12.776.377.715.548.114.224.200.375] baziliximab [d12.776.377.715.548.114.224.200.407] bevacizumab [d12.776.377.715.548.114.224.200.438] brentuximab vedotin [d12.776.377.715.548.114.224.200.469] certolizumab pegol `[d12.776.377.715.548.114.224.200.500]` cetuximab [d12.776.377.715.548.114.224.200.750] daklizumab [d12.776.377.715.548.114.224.200.766] denosumab [d12.776.377.715.548.114.224.200.782] gemtuzumab [d12.776.377.715.548.114.224.200.790] inotuzumab ozogamicín [d12.776.377.715.548.114.224.200.794] ipilimumab [d12.776.377.715.548.114.224.200.798] natalizumab [d12.776.377.715.548.114.224.200.813] nivolumab [d12.776.377.715.548.114.224.200.829] omalizumab [d12.776.377.715.548.114.224.200.844] palivizumab [d12.776.377.715.548.114.224.200.860] panitumumab [d12.776.377.715.548.114.224.200.864] ramucirumab [d12.776.377.715.548.114.224.200.866] ranibizumab [d12.776.377.715.548.114.224.200.868] trastuzumab [d12.776.377.715.548.114.224.200.875] + ustekinumab [d12.776.377.715.548.114.224.200.937]
	`[d12.776.377.715.548.680.650.250]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + globulíny [d12.776.377] + globulíny sérové [d12.776.377.715] + imunoglobulíny [d12.776.377.715.548] + fragmenty imunoglobulínov [d12.776.377.715.548.680] + Fab fragmenty imunoglobulínov [d12.776.377.715.548.680.650] + abciximab [d12.776.377.715.548.680.650.125] certolizumab pegol `[d12.776.377.715.548.680.650.250]` oblasť imunoglobulínov, variabilná [d12.776.377.715.548.680.650.500] + tuftsín [d12.776.377.715.548.680.650.750]

subject heading

subject heading

Number of the records: 1

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.